Neurodegeneration trajectory in pediatric and adult/late DM1: A follow-up MRI study across a decade

Ann Clin Transl Neurol. 2020 Oct;7(10):1802-1815. doi: 10.1002/acn3.51163. Epub 2020 Sep 2.

Abstract

Objective: To characterize the progression of brain structural abnormalities in adults with pediatric and adult/late onset DM1, as well as to examine the potential predictive markers of such progression.

Methods: 21 DM1 patients (pediatric onset: N = 9; adult/late onset: N = 12) and 18 healthy controls (HC) were assessed longitudinally over 9.17 years through brain MRI. Additionally, patients underwent neuropsychological, genetic, and muscular impairment assessment. Inter-group comparisons of total and voxel-level regional brain volume were conducted through Voxel Based Morphometry (VBM); cross-sectionally and longitudinally, analyzing the associations between brain changes and demographic, clinical, and cognitive outcomes.

Results: The percentage of GM loss did not significantly differ in any of the groups compared with HC and when assessed independently, adult/late DM1 patients and their HC group suffered a significant loss in WM volume. Regional VBM analyses revealed subcortical GM damage in both DM1 groups, evolving to frontal regions in the pediatric onset patients. Muscular impairment and the outcomes of certain neuropsychological tests were significantly associated with follow-up GM damage, while visuoconstruction, attention, and executive function tests showed sensitivity to WM degeneration over time.

Interpretation: Distinct patterns of brain atrophy and its progression over time in pediatric and adult/late onset DM1 patients are suggested. Results indicate a possible neurodevelopmental origin of the brain abnormalities in DM1, along with the possible existence of an additional neurodegenerative process. Fronto-subcortical networks appear to be involved in the disease progression at young adulthood in pediatric onset DM1 patients. The involvement of a multimodal integration network in DM1 is discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Atrophy / pathology
  • Disease Progression
  • Executive Function / physiology*
  • Female
  • Follow-Up Studies
  • Gray Matter / pathology
  • Humans
  • Magnetic Resonance Imaging* / methods
  • Male
  • Middle Aged
  • Myotonic Dystrophy / pathology*
  • Neurodegenerative Diseases / pathology*
  • Neuropsychological Tests
  • White Matter / pathology

Grants and funding

This work was funded by CIBERNED grant 609; Eusko Jaurlaritza grants PRE_2016_1_0187, PRE_2019_1_0070, and SAIO08‐PE08BF01; Institute of Health Carlos III co‐founded by Fondo Europeo de Desarrollo Regional‐FEDER grants PI17/01231 and PI17/01841.